{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:02:32Z","timestamp":1777406552536,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004242","name":"Princess Nourah bint Abdulrahman University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.saa.2024.124596","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T12:09:18Z","timestamp":1717589358000},"page":"124596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A nano-level assay of tizanidine using the fluorogenic character of benzofurazan derivative: Application to plasma, tablets, and content homogeneity evaluation"],"prefix":"10.1016","volume":"320","author":[{"given":"Huda Salem","family":"AlSalem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Naif","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona Saad","family":"Binkadem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soha Talal","family":"Al-Goul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A.","family":"Abu-hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5965-7387","authenticated-orcid":false,"given":"Mohamed","family":"Oraby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Abdel-Lateef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.saa.2024.124596_b0005","first-page":"S6","article-title":"Tizanidine: neuropharmacology and mechanism of action","volume":"44","author":"Coward","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.saa.2024.124596_b0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1185\/030079908X261113","article-title":"A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury","volume":"24","author":"Kamen","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.saa.2024.124596_b0015","first-page":"403","article-title":"Development and validation of new analytical method for the estimation of tizanidine hydrochloride in bulk and in formulation by UV spectrophotometric method","volume":"3","author":"Paladugu","year":"2013","journal-title":"Int. J. Pharma Sci."},{"key":"10.1016\/j.saa.2024.124596_b0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejfs.2011.04.005","article-title":"A simple kinetic spectrophotometric method for determination of Tizanidine hydrochloride in pharmaceutical preparations","volume":"1","author":"Hassouna","year":"2011","journal-title":"Egypt. J. Forensic Sci."},{"key":"10.1016\/j.saa.2024.124596_b0025","first-page":"2107","article-title":"Estimation of tizanidine hydrochloride by UV-spectrophotometric method","volume":"3","author":"Chakravarty","year":"2010","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.saa.2024.124596_b0030","unstructured":"A. Giri, B. Saritha, T.S. Reddy, Quantitative Estimation of Tizanidine in Pharmaceutical Formulations by Visible Spectrophotometry Using Gold (III)."},{"key":"10.1016\/j.saa.2024.124596_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-153X-5-60","article-title":"Spectrophotometric determination of tizanidine and orphenadrine via ion pair complex formation using eosin Y","volume":"5","author":"Walash","year":"2011","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.saa.2024.124596_b0040","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0731-7085(03)00304-2","article-title":"Stability-indicating HPTLC determination of tizanidine hydrochloride in bulk drug and pharmaceutical formulations","volume":"33","author":"Mahadik","year":"2003","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2024.124596_b0045","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/bio.1367","article-title":"Sensitive spectrofluorimetric determination of tizanidine in pharmaceutical preparations, human plasma and urine through derivatization with dansyl chloride","volume":"27","author":"Ulu","year":"2012","journal-title":"Luminescence"},{"key":"10.1016\/j.saa.2024.124596_b0050","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/00032719208020061","article-title":"A study on the polarographic behaviour determination of tizanidine","volume":"25","author":"Tun\u00e7el","year":"1992","journal-title":"Anal. Lett."},{"key":"10.1016\/j.saa.2024.124596_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2021.106956","article-title":"Ultra-sensitive detection of tizanidine in commercial tablets and urine samples using zinc oxide coated glassy carbon electrode","volume":"172","author":"Killedar","year":"2022","journal-title":"Microchem. J."},{"key":"10.1016\/j.saa.2024.124596_b0060","first-page":"1162","article-title":"Stability indicating RP-HPLC method development and validation for the analysis of tizanidine in bulk and pharmaceutical formulation","volume":"12","author":"Rajesh","year":"2020","journal-title":"J. Pharm. Sci. Res."},{"key":"10.1016\/j.saa.2024.124596_b0065","doi-asserted-by":"crossref","DOI":"10.4103\/0250-474X.25725","article-title":"Simultaneous spectrophotometric determination of valdecoxib and tizanidine in tablets","volume":"68","author":"Sivasubramanian","year":"2006","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.saa.2024.124596_b0070","article-title":"New spectrophotometric methods applied to the simultaneous determination of diclofenac potassium and tizanidine","volume":"68","author":"Kumar","year":"2006","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.saa.2024.124596_b0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jpba.2004.09.036","article-title":"Application of HPLC and HPTLC for the simultaneous determination of tizanidine and rofecoxib in pharmaceutical dosage form","volume":"37","author":"Kaul","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2024.124596_b0080","article-title":"HPTLC method for the simultaneous estimation of Tizanidine and Rofecoxib in tablets","volume":"68","author":"Ravi","year":"2006","journal-title":"Indian J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.saa.2024.124596_b0085","article-title":"Conductometric determination of dropropizine and tizanidine hydrochloride in their pharmaceutical formulations","volume":"7","author":"Elwy","year":"2015","journal-title":"Anal. Bioanal. Electrochem."},{"key":"10.1016\/j.saa.2024.124596_b0090","doi-asserted-by":"crossref","DOI":"10.4103\/0250-474X.29647","article-title":"Simultaneous Estimation of Valdecoxib and Tizanidine Hydrochloride in Tablets by RP-HPLC","volume":"68","author":"Puranik","year":"2006","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.saa.2024.124596_b0095","first-page":"84","article-title":"A validated reversed phase HPLC-method for the determination of aceclofenac and tizanidine in tablets","author":"Kumar","year":"2010","journal-title":"Asian J. Pharm. Res. Health Care"},{"key":"10.1016\/j.saa.2024.124596_b0100","article-title":"Simultaneous RPHPLC determination of nimesulide and tizanidine in tablets","volume":"69","author":"Nimje","year":"2007","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.saa.2024.124596_b0105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1155\/2010\/323410","article-title":"Simultaneous RP HPLC determination of aceclofenac, paracetamol and tizanidine in pharmaceutical preparations","volume":"7","author":"Vaidya","year":"2010","journal-title":"J. Chem."},{"key":"10.1016\/j.saa.2024.124596_b0110","first-page":"1","article-title":"A unique application of pentane-2, 4-dione as a fluorogenic probe of dipeptidyl peptidase-4 enzyme inhibitor medicament assay in pharmaceutical and biological matrices","author":"El Hamd","year":"2023","journal-title":"Chem. Pap."},{"key":"10.1016\/j.saa.2024.124596_b0115","doi-asserted-by":"crossref","DOI":"10.1002\/bio.4502","article-title":"A new application of isoindole fluorophore derivative in Sitagliptin anti-diabetic medication assay: application to dosage forms and biological fluids evaluation","author":"El Hamd","year":"2023","journal-title":"Luminescence"},{"key":"10.1016\/j.saa.2024.124596_b0120","first-page":"1","article-title":"Development of Eco-friendly scattering and fluorimetric methods for the determination of clemastine through its interaction with Eosin Y: assessment of whiteness, blueness, and greenness tools","author":"Abdel-Lateef","year":"2024","journal-title":"J. Fluoresc."},{"key":"10.1016\/j.saa.2024.124596_b0125","article-title":"Synthesis of green emitted carbon dots from Vachellia nilotica and utilizing its extract as a red emitted fluorescence reagent: applying for visual and spectroscopic detection of iron (III)","volume":"295","author":"AlSalem","year":"2023","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2024.124596_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114941","article-title":"A specific turn-on fluorescence probe for determination of nitazoxanide based on feasible oxidation reaction with hypochlorite: applying cobalt ferrite nanoparticles for pre-concentration and extraction of its metabolite from real urine samples","volume":"219","author":"Abdel-Lateef","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2024.124596_b0135","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s11696-021-01894-3","article-title":"Spectrofluorimetric determination of \u03b1-difluoromethylornithine through condensation with ninhydrin and phenylacetaldehyde: application to pharmaceutical cream and spiked urine samples","volume":"76","author":"Abdel-Lateef","year":"2022","journal-title":"Chem. Pap."},{"key":"10.1016\/j.saa.2024.124596_b0140","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.210366","article-title":"Application of Hantzsch reaction for sensitive determination of eflornithine in cream, plasma and urine samples","volume":"8","author":"Almahri","year":"2021","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.saa.2024.124596_b0145","doi-asserted-by":"crossref","first-page":"e4748","DOI":"10.1002\/bio.4748","article-title":"Study on the interaction between erythrosine B and the cardiac drug amiodarone using fluorescence, scattering, and absorbance spectra and their analytical application","volume":"39","author":"AlSalem","year":"2024","journal-title":"Luminescence"},{"key":"10.1016\/j.saa.2024.124596_b0150","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/bio.3725","article-title":"Novel spectrofluorimetric quantification of alogliptin benzoate in biofluids exploiting its interaction with 4-chloro-7-nitrobenzofurazan","volume":"35","author":"Aref","year":"2020","journal-title":"Luminescence"},{"key":"10.1016\/j.saa.2024.124596_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2023.122390","article-title":"Application of isoindole fluorophore formation for determination of linagliptin in the sole and co-formulated tablets: Application for plasma assay and content uniformity testing","volume":"291","author":"Abu-Hassan","year":"2023","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2024.124596_b0160","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.saa.2017.09.059","article-title":"Derivatization of labetalol hydrochloride for its spectrofluorimetric and spectrophotometric determination inhuman plasma: application to stability study","volume":"190","author":"Omar","year":"2018","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2024.124596_b0165","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.microc.2018.12.018","article-title":"Innovative ultra-sensitive spectrofluorimetric method for nanogram detection of doripenem monohydrate in human plasma, urine and pharmaceutical formulation","volume":"145","author":"Salman","year":"2019","journal-title":"Microchem. J."},{"key":"10.1016\/j.saa.2024.124596_b0170","doi-asserted-by":"crossref","first-page":"22154","DOI":"10.1039\/C8RA03614D","article-title":"Utility of the chromogenic and fluorogenic properties of benzofurazan for the assay of milnacipran in human urine and plasma","volume":"8","author":"Mostafa","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.saa.2024.124596_b0175","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1039\/an9830801067","article-title":"Relative fluorescence quantum yields using a computer-controlled luminescence spectrometer","volume":"108","author":"Williams","year":"1983","journal-title":"Analyst"},{"key":"10.1016\/j.saa.2024.124596_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2021.119806","article-title":"Micellar sensitized Resonance Rayleigh Scattering and spectrofluorometric methods based on isoindole formation for determination of Eflornithine in cream and biological samples","volume":"258","author":"Abdel-Lateef","year":"2021","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2024.124596_b0185","unstructured":"M. Rockville, The United States Pharmacopoeia 30, the National Formulary 25 US Pharmacopeial Convention, Electronic version, (2007) 2287-2288."}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142524007625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142524007625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T04:41:59Z","timestamp":1732164119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142524007625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":37,"alternative-id":["S1386142524007625"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2024.124596","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A nano-level assay of tizanidine using the fluorogenic character of benzofurazan derivative: Application to plasma, tablets, and content homogeneity evaluation","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2024.124596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124596"}}